BETOPTIC S- betaxolol hydrochloride suspension/ drops United States - English - NLM (National Library of Medicine)

betoptic s- betaxolol hydrochloride suspension/ drops

novartis pharmaceuticals corporation - betaxolol hydrochloride (unii: 6x97d2xt0o) (betaxolol - unii:o0zr1r6rz2) - betoptic s® (betaxolol hydrochloride ophthalmic suspension) 0.25% is indicated for the treatment of elevated intraocular pressure (iop) in patients with chronic open-angle glaucoma or ocular hypertension. betoptic s is contraindicated in patients with: - sinus bradycardia - greater than a first degree atrioventricular (av) block - cardiogenic shock - patients with overt cardiac failure - hypersensitivity to any component of this product risk summary there are no adequate and well-controlled studies of betoptic s administration in pregnant women to inform a drug-associated risk. there are limited data with the use of betaxolol eye drops in pregnant women. epidemiological studies have not revealed malformative effects but show a risk for intrauterine growth retardation when beta-blockers are administered by the oral route. in animal reproductive studies, no drug-induced maternal toxicity or teratogenicity was observed at clinically relevant doses (see data) . because animal reproductive studies are not always

BETOPTIC Eye Drops Solution 0.5%w/v %w/v Ireland - English - HPRA (Health Products Regulatory Authority)

betoptic eye drops solution 0.5%w/v %w/v

pco manufacturing - betaxolol hydrochloride - eye drops solution - 0.5%w/v %w/v

BETOPTIC Eye Drops Solution 0.5 %w/v Ireland - English - HPRA (Health Products Regulatory Authority)

betoptic eye drops solution 0.5 %w/v

g & a licensing limited - betaxolol hydrochloride - eye drops solution - 0.5 %w/v

BETOPTIC Eye Drops Solution 0.5 Base %w/v Ireland - English - HPRA (Health Products Regulatory Authority)

betoptic eye drops solution 0.5 base %w/v

ltt pharma limited - betaxolol hydrochloride - eye drops solution - 0.5 base %w/v

BETOPTIC 0.25% EYEDROPS Ireland - English - HPRA (Health Products Regulatory Authority)

betoptic 0.25% eyedrops

alcon laboratories (uk) ltd - betaxolol hydrochloride - eye drops suspension - 0.25 %w/v

BETOPTIC 0.5 %w/v Eye Drops Solution Ireland - English - HPRA (Health Products Regulatory Authority)

betoptic 0.5 %w/v eye drops solution

g & a licensing limited - betaxolol hydrochloride - eye drops solution - 0.5 %w/v

BETOPTIC 0.25% EYEDROPS 0.25 %w/v Eye Drops Suspension Ireland - English - HPRA (Health Products Regulatory Authority)

betoptic 0.25% eyedrops 0.25 %w/v eye drops suspension

alcon laboratories (uk) ltd - betaxolol hydrochloride - eye drops suspension - 0.25 %w/v

BETOPTIC SUSPENSION SINGLE DOSE 0.25 %w/v Eye Drops Suspension Ireland - English - HPRA (Health Products Regulatory Authority)

betoptic suspension single dose 0.25 %w/v eye drops suspension

alcon laboratories (uk) ltd - betaxolol hydrochloride - eye drops suspension - 0.25 %w/v - beta blocking agents

BETOPTIC 0.5 %w/v Eye Drops Solution Ireland - English - HPRA (Health Products Regulatory Authority)

betoptic 0.5 %w/v eye drops solution

novartis pharmaceuticals uk ltd - betaxolol hydrochloride - eye drops solution - 0.5 %w/v - beta blocking agents

BETOPTIC SUSPENSION SINGLE DOSE 0.25 %w/v Eye Drops Suspension Ireland - English - HPRA (Health Products Regulatory Authority)

betoptic suspension single dose 0.25 %w/v eye drops suspension

novartis pharmaceuticals uk ltd - betaxolol hydrochloride - eye drops suspension - 0.25 %w/v - beta blocking agents